Literature DB >> 22041510

Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts.

Muriel Genevay1, Mari Mino-Kenudson, Kurt Yaeger, Ioannis T Konstantinidis, Cristina R Ferrone, Sarah Thayer, Carlos Fernandez-del Castillo, Dushyant Sahani, Brenna Bounds, David Forcione, William R Brugge, Martha Bishop Pitman.   

Abstract

OBJECTIVE: Evaluate the value of cytology relative to imaging features in risk assessment for malignancy as defined in the Sendai Guidelines.
BACKGROUND: The Sendai Guidelines list symptoms, cyst size >30 mm, dilated main pancreatic duct (MPD) >6 mm, mural nodule (MN) and "positive" cytology as high risk stigmata for malignancy warranting surgical triage.
METHODS: We reviewed clinical, radiological and cytological data of 112 patients with histologically confirmed mucinous cysts of the pancreas evaluated in a single tertiary medical center. Cytology slides were blindly re-reviewed and epithelial cells grouped as either benign or high-grade atypia (HGA) [≥high-grade dysplasia]. Histologically, neoplasms were grouped as benign (low-grade and moderate dysplasia) and malignant (in situ and invasive carcinoma). Performance characteristics of cytology relative to other risk factors were evaluated.
RESULTS: Dilated MPD, MN, and HGA were independent predictors of malignancy (p < 0.0001), but not symptoms (p = 0.29) or cyst size >30 mm (p = 0.51). HGA was the most sensitive predictor of malignancy in all cysts (72%) and in small (≤30 mm) branch-duct intraductal papillary mucinous neoplasm (BD IPMN; 67%), whereas also being specific (85 and 88%, respectively). MN and dilated MPD were highly specific (>90%), but insensitive (39%-44%). Cytology detected 30% more cancers in small cysts than dilated MPD or MN and half of the cancers without either of these high-risk imaging features.
CONCLUSIONS: Cytology adds value to the radiological assessment of predicting malignancy in mucinous cysts, particularly in small BD IPMN.

Entities:  

Mesh:

Year:  2011        PMID: 22041510      PMCID: PMC3817564          DOI: 10.1097/SLA.0b013e3182383118

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  53 in total

1.  Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Takuya Mimura; Atsuhiro Masuda; Ippei Matsumoto; Hideyuki Shiomi; Shiei Yoshida; Maki Sugimoto; Tsuyoshi Sanuki; Masaru Yoshida; Tsuyoshi Fujita; Hiromu Kutsumi; Yonsou Ku; Takeshi Azuma
Journal:  J Clin Gastroenterol       Date:  2010-10       Impact factor: 3.062

2.  Incidental pancreatic cysts: do we really know what we are watching?

Authors:  Camilo Correa-Gallego; Cristina R Ferrone; Sarah P Thayer; Jennifer A Wargo; Andrew L Warshaw; Carlos Fernández-Del Castillo
Journal:  Pancreatology       Date:  2010-05-17       Impact factor: 3.996

3.  Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases.

Authors:  Pierre Bernard; Jean-Yves Scoazec; Madeleine Joubert; Xavier Kahn; Joël Le Borgne; Françoise Berger; Christian Partensky
Journal:  Arch Surg       Date:  2002-11

4.  Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.

Authors:  Carlos Fernández-del Castillo; Javier Targarona; Sarah P Thayer; David W Rattner; William R Brugge; Andrew L Warshaw
Journal:  Arch Surg       Date:  2003-04

5.  MR cholangiopancreatographic differentiation of benign and malignant intraductal mucin-producing tumors of the pancreas.

Authors:  H Irie; H Honda; H Aibe; T Kuroiwa; K Yoshimitsu; K Shinozaki; K Yamaguchi; M Shimada; K Masuda
Journal:  AJR Am J Roentgenol       Date:  2000-05       Impact factor: 3.959

6.  Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas?

Authors:  N A Ahmad; M L Kochman; J D Lewis; G G Ginsberg
Journal:  Am J Gastroenterol       Date:  2001-12       Impact factor: 10.864

7.  Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Toshifumi Matsumoto; Masanori Aramaki; Kazuhiro Yada; Seitaro Hirano; Yoshihisa Himeno; Kohei Shibata; Katsunori Kawano; Seigo Kitano
Journal:  J Clin Gastroenterol       Date:  2003-03       Impact factor: 3.062

8.  Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions.

Authors:  Nuzhat A Ahmad; Michael L Kochman; Colleen Brensinger; William R Brugge; Douglas O Faigel; Frank G Gress; Michael B Kimmey; Nicholas J Nickl; Thomas J Savides; Michael B Wallace; Maurits J Wiersema; Gregory G Ginsberg
Journal:  Gastrointest Endosc       Date:  2003-07       Impact factor: 9.427

9.  Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.

Authors:  Chad A Wiesenauer; C Max Schmidt; Oscar W Cummings; Constantin T Yiannoutsos; Thomas J Howard; Eric A Wiebke; Robert J Goulet; Lee McHenry; Stuart Sherman; Glen A Lehman; Harvey Cramer; James A Madura
Journal:  Arch Surg       Date:  2003-06

10.  Intraductal papillary mucinous tumors of the pancreas. Comparison of helical CT and MR imaging.

Authors:  Y Fukukura; F Fujiyoshi; H Hamada; S Takao; T Aikou; N Hamada; S Yonezawa; M Nakajo
Journal:  Acta Radiol       Date:  2003-09       Impact factor: 1.701

View more
  32 in total

Review 1.  IPMN: surgical treatment.

Authors:  Reto M Käppeli; Sascha A Müller; Bianka Hummel; Christina Kruse; Philip Müller; Jürgen Fornaro; Alexander Wilhelm; Marcel Zadnikar; Bruno M Schmied; Ignazio Tarantino
Journal:  Langenbecks Arch Surg       Date:  2013-09-03       Impact factor: 3.445

Review 2.  To cease or 'de-cyst'? The evaluation and management of pancreatic cystic lesions.

Authors:  Brintha K Enestvedt; Nuzhat Ahmad
Journal:  Curr Gastroenterol Rep       Date:  2013-10

3.  Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations.

Authors:  Catherine G Fischer; Violeta Beleva Guthrie; Alicia M Braxton; Lily Zheng; Pei Wang; Qianqian Song; James F Griffin; Peter E Chianchiano; Waki Hosoda; Noushin Niknafs; Simeon Springer; Marco Dal Molin; David Masica; Robert B Scharpf; Elizabeth D Thompson; Jin He; Christopher L Wolfgang; Ralph H Hruban; Nicholas J Roberts; Anne Marie Lennon; Yuchen Jiao; Rachel Karchin; Laura D Wood
Journal:  Gastroenterology       Date:  2019-06-05       Impact factor: 22.682

4.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

5.  The value of cyst fluid analysis in the pre-operative evaluation of pancreatic cysts.

Authors:  Martha Bishop Pitman; William R Brugge; Andrew L Warshaw
Journal:  J Gastrointest Oncol       Date:  2011-12

Review 6.  [Cystic pancreatic tumors: diagnostics and new biomarkers].

Authors:  A W Berger; T Seufferlein; A Kleger
Journal:  Chirurg       Date:  2017-11       Impact factor: 0.955

Review 7.  Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Víctor M Castellano-Megías; Carolina Ibarrola-de Andrés; Guadalupe López-Alonso; Francisco Colina-Ruizdelgado
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

Review 8.  International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masao Tanaka
Journal:  Ann Transl Med       Date:  2015-11

9.  Routine Cyst Fluid Cytology Is Not Indicated in the Evaluation of Pancreatic Cystic Lesions.

Authors:  Lawrence A Shirley; Jon Walker; Somashekar Krishna; Samer El-Dika; Peter Muscarella; E Christopher Ellison; Carl R Schmidt; Mark Bloomston
Journal:  J Gastrointest Surg       Date:  2016-05-26       Impact factor: 3.452

10.  Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.

Authors:  Klaus Sahora; Carlos Fernández-del Castillo; Fei Dong; Giovanni Marchegiani; Sarah P Thayer; Cristina R Ferrone; Dushyant V Sahani; William R Brugge; Andrew L Warshaw; Keith D Lillemoe; Mari Mino-Kenudson
Journal:  Surgery       Date:  2014-07-28       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.